OVARIAN SEROUS TUMOR
Clinical trials for OVARIAN SEROUS TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may offer alternative to chemo for ovarian cancer
Disease control OngoingThis study tested whether the targeted drugs olaparib (alone or with cediranib) work better than standard platinum-based chemo for women with ovarian, fallopian tube, or peritoneal cancer that came back after initial treatment. About 579 women with platinum-sensitive cancer took …
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
New hope for Drug-Resistant ovarian cancer: experimental combo shows promise
Disease control OngoingThis study tests whether adding an experimental drug called M6620 to standard chemotherapy (gemcitabine) works better than gemcitabine alone for women with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based treatments. About 70 par…
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:51 UTC